SCHEMBL2638283

SCHEMBL2638283

Cc1cc(CC(=O)Nc2ccc(S(N)(=O)=O)cc2)cc(Oc2cc(C#N)ccc2Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.47
CA2 P00918 9/20 0.47
CA12 O43570 8/20 0.47
CA9 Q16790 8/20 0.47
P2RX4 Q99571 3/20 0.45
RORC P51449 3/20 0.44
CA5A P35218 2/20 0.43
CA7 P43166 2/20 0.43
CA5B Q9Y2D0 2/20 0.43
CA14 Q9ULX7 1/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638728 0.91 CA1 (0.54) CA1CA2CA12CA9P2RX4
SCHEMBL2639653 0.91 CA1 (0.47) CA1CA2CA12CA9P2RX4
SCHEMBL2638171 0.90 CA1 (0.55) CA1CA2CA12CA9CA5A
SCHEMBL2639153 0.89 CA1 (0.47) CA1CA2CA12CA9RORC
SCHEMBL2638824 0.86 CA1 (0.51) CA1CA2CA12CA9P2RX4
SCHEMBL2640174 0.84 CA1 (0.54) CA1CA2CA12CA9P2RX4
SCHEMBL4602754 0.84 CA1 (0.53) CA1CA2CA12CA9P2RX4
SCHEMBL2638658 0.82 CA1 (0.52) CA1CA2CA12CA9P2RX4
SCHEMBL2638407 0.82 CA1 (0.53) CA1CA2CA12CA9P2RX4
SCHEMBL14626270 0.82 CA1 (0.48) CA1CA2CA12CA9P2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4810529-B2 2011-11-09 JP claimed
EP-1742908-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2009-11-11 EP claimed
EP-1742908-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2007-01-17 EP claimed
WO-2005102989-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2005-11-03 WO claimed
EP-1742908-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2009-11-11 EP disclosed